Johnson & Johnson (JNJ)
158.24
-1.89
(-1.18%)
USD |
NYSE |
Nov 04, 16:00
158.05
-0.19
(-0.12%)
Pre-Market: 08:32
Johnson & Johnson Cash from Operations (Quarterly): 7.993B for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 7.993B |
| June 30, 2024 | 5.633B |
| March 31, 2024 | 3.657B |
| December 31, 2023 | 7.863B |
| September 30, 2023 | 7.489B |
| June 30, 2023 | 4.182B |
| March 31, 2023 | 3.257B |
| December 31, 2022 | 5.35B |
| September 30, 2022 | 6.284B |
| June 30, 2022 | 5.581B |
| March 31, 2022 | 3.979B |
| December 31, 2021 | 5.732B |
| September 30, 2021 | 8.29B |
| June 30, 2021 | 5.314B |
| March 31, 2021 | 4.074B |
| December 31, 2020 | 8.343B |
| September 30, 2020 | 8.383B |
| June 30, 2020 | 3.452B |
| March 31, 2020 | 3.358B |
| December 31, 2019 | 6.398B |
| September 30, 2019 | 7.527B |
| June 30, 2019 | 5.948B |
| March 31, 2019 | 3.543B |
| December 31, 2018 | 6.244B |
| September 30, 2018 | 6.272B |
| Date | Value |
|---|---|
| June 30, 2018 | 6.079B |
| March 31, 2018 | 3.606B |
| December 31, 2017 | 6.105B |
| September 30, 2017 | 6.266B |
| June 30, 2017 | 5.772B |
| March 31, 2017 | 2.913B |
| December 31, 2016 | 6.653B |
| September 30, 2016 | 5.361B |
| June 30, 2016 | 4.564B |
| March 31, 2016 | 2.189B |
| December 31, 2015 | 5.085B |
| September 30, 2015 | 6.14B |
| June 30, 2015 | 5.472B |
| March 31, 2015 | 2.872B |
| December 31, 2014 | 4.604B |
| September 30, 2014 | 4.654B |
| June 30, 2014 | 5.529B |
| March 31, 2014 | 3.923B |
| December 31, 2013 | 4.139B |
| September 30, 2013 | 5.947B |
| June 30, 2013 | 5.051B |
| March 31, 2013 | 2.277B |
| December 31, 2012 | 3.376B |
| September 30, 2012 | 4.98B |
| June 30, 2012 | 4.245B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
3.257B
Minimum
Mar 2023
8.383B
Maximum
Sep 2020
5.731B
Average
5.607B
Median
Cash from Operations (Quarterly) Benchmarks
| Amgen Inc | 3.571B |
| Eli Lilly and Co | 3.712B |
| Merck & Co Inc | 5.637B |
| Pfizer Inc | -1.781B |
| AbbVie Inc | 5.447B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -3.128B |
| Cash from Financing (Quarterly) | -9.882B |
| Free Cash Flow | 19.02B |
| Free Cash Flow Per Share (Quarterly) | 2.354 |
| Free Cash Flow to Equity (Quarterly) | 11.45B |
| Free Cash Flow to Firm (Quarterly) | 5.714B |
| Free Cash Flow Yield | 4.95% |